$19.78
0.190.97%
Pre-Market: 4:13 PM EDT
15 minutes delayed
NewAmsterdam Pharma
NAMSNASDAQ
NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Earnings Estimates, EPS, And Revenue
NewAmsterdam Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$6.9M
Analyze the earnings history of NewAmsterdam Pharma using advanced sorting and filters.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
No data available to display | ||||||||||||
NewAmsterdam Pharma (NAMS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
NewAmsterdam Pharma (NAMS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is NewAmsterdam Pharma (NASDAQ:NAMS) reporting earnings?
There are no earnings for NewAmsterdam Pharma
What were the latest earnings per share (EPS) for NewAmsterdam Pharma (NASDAQ:NAMS)?
There are no earnings for NewAmsterdam Pharma
What were NewAmsterdam Pharma’s (NASDAQ:NAMS) revenues?
There are no earnings for NewAmsterdam Pharma
Browse earnings estimates, EPS, and revenue on all stocks.